Evolution of incipient nephropathy in type 2 diabetes mellitus
about
Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway fluxMicroalbuminuria in diabetes mellitus.Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.Podocyte detachment in type 2 diabetic nephropathy.Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients.Diet-Induced Podocyte Dysfunction in Drosophila and Mammals.Urinary excretion of viable podocytes in health and renal disease.Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians.Research into the glomerular podocyte--is it relevant to diabetic nephropathy?Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelinesDipstick urinalysis for diabetes screening in TB patients.Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes.Temporal profile of diabetic nephropathy pathologic changes.Pathophysiology of the diabetic kidney.Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis.Ras activation modulates methylglyoxal-induced mesangial cell apoptosis through superoxide production.Association between urinary IgG and relative risk for factors affecting proteinuria in type 2 diabetic patients.Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.Diabetic kidney disease.A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.Modeling GFR trajectories in diabetic nephropathy.DW1029M, a novel botanical drug candidate, inhibits advanced glycation end-product formation, rat lens aldose reductase activity, and TGF-β1 signaling.Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects.Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians
P2860
Q33655472-5167CAEF-D170-4231-BB95-494CF89227D6Q34004759-A42D723F-B986-4F63-B9ED-18FED485551CQ35004388-D27A33BC-B9A9-445A-B317-5D9881D2FE9AQ35063584-AA75E726-4047-4C1D-B5C2-A3E011A80ECEQ35888006-65F10A69-4633-4DCB-BC60-783C8677467AQ35941157-3FA08582-BA50-4922-BA58-3E651A8B3779Q36012253-427248B1-23A9-490C-8631-B743BC96D80FQ36319830-7F76BA78-EBEC-4BBF-AD76-49DD3DF779C1Q36345206-96735193-C43F-4A84-B057-55B3285BCF95Q36536737-D170C5C9-5522-44A9-AA62-A55436D22E48Q36834059-ADC5A8A6-87AE-4175-ACB0-ABA5D1AF9840Q36921393-AE8124B7-DBE9-45E9-8718-E8A01F29C402Q37110523-651771FC-C72C-40E9-A01B-4071D2515A7BQ38109847-34699600-0420-4C07-912E-4FC7D9112CBEQ38111707-27F8E514-97BB-462A-8D0D-98AF804540A6Q38654795-D17F71E8-E77A-40CA-9751-913BDC71CC49Q40053888-2A022D51-1E31-4E07-9117-528D353FD373Q42057634-C15D8F9A-7BD9-4048-8C99-2A6E4BD78C27Q42363114-45D9D782-BAE4-4F09-BEB1-55B55A2E9A79Q43721013-9833E477-E511-42EA-8331-C3965A6C6C5AQ45972129-3FB35180-725A-48E8-8763-3773C96F89A1Q46495855-D967FAD6-666D-482F-9660-DD50002F470CQ46910833-FDB42E72-2D0C-46EB-AD31-D55126384BAEQ50795437-4D8E5CC1-1B9D-4668-8810-1D99E67E9D45Q59150529-2899DE06-D587-43DD-8A53-E965079F07D9
P2860
Evolution of incipient nephropathy in type 2 diabetes mellitus
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evolution of incipient nephropathy in type 2 diabetes mellitus
@ast
Evolution of incipient nephropathy in type 2 diabetes mellitus
@en
Evolution of incipient nephropathy in type 2 diabetes mellitus
@nl
type
label
Evolution of incipient nephropathy in type 2 diabetes mellitus
@ast
Evolution of incipient nephropathy in type 2 diabetes mellitus
@en
Evolution of incipient nephropathy in type 2 diabetes mellitus
@nl
prefLabel
Evolution of incipient nephropathy in type 2 diabetes mellitus
@ast
Evolution of incipient nephropathy in type 2 diabetes mellitus
@en
Evolution of incipient nephropathy in type 2 diabetes mellitus
@nl
P2093
P1433
P1476
Evolution of incipient nephropathy in type 2 diabetes mellitus
@en
P2093
I Abdullah
K V Lemley
P H Bennett
R G Nelson
P304
P356
10.1046/J.1523-1755.2000.00223.X
P407
P577
2000-09-01T00:00:00Z
P5875
P6179
1047905388